By proceeding, you agree to our Terms of Use and Privacy Policy.
Ncardia is a human iPSC technology company that operates worldwide with facilities, offices and staff throughout Europe and North America.
23-24 June 2022
Following 20 years of connecting the drug discovery and preclinical research community, Cambridge Healthtech Institute brings together thought leaders from pharma, biotech, academia, CROs and technology providers to drive innovation, share the latest
Event Ended
Hybrid
Paid
Boston
17-20 October 2022
Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules. We
25-27 April 2023
In 2023, there will be significant interest in glial cell models, neuroinflammatory biomarkers, and optimizing approaches to target LRKK2, TREM2, and other neurological indications. As a result, large biopharmaceutical companies are expanding their d
USA